| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd7c27b9ec61781656e6f039702fd568 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 |
| filingDate |
2011-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e50dcad24b0580d177463b76b242f8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_429a47dd109572c1011bef0eead74e79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1de468afda4cb6224661b2aaea45b7f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3369b31665c53627de26d2c48c87c70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb064fb4be406f9819f2402d1a44c5dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c54fa20dd8c6c1f649a8a7e308e0bcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_273e49ac48b0734c839ed74347de6db3 |
| publicationDate |
2013-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20130008976-A |
| titleOfInvention |
Pharmaceutical composition for anti-herpes virus containing oxonaphthalene-based compound that inhibits herpes virus exonuclease activity as an active ingredient |
| abstract |
The present invention provides an oxonaphthalene-based compound or a pharmaceutically acceptable salt thereof, which inhibits the herpesvirus exonuclease activity represented by Formula 3 or 4, respectively, as an active ingredient. According to the present invention described above, there is an advantage that the herpes virus exonucleolytic activity can be inhibited and the diseases or diseases caused by the herpes virus such as gamma herpes virus can be effectively treated or prevented without drug toxicity or drug resistance. |
| priorityDate |
2011-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |